Key facts
- This page summarizes Michael Moore's Form 4 filing for VIEMED HEALTHCARE, INC. (VMD).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 20 Jan 2022, 16:37.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Award
Additional SEC filing notes
Footnote F1
Options granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.
Footnote F2
Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
Footnote F3
Restricted Stock Units granted to reporting person on January 18, 2022, which vest in three equal installments beginning on the first anniversary of the grant date.
Footnote F4
Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
Footnote F5
Represents an award granted in 2022 under the Issuer's Phantom Share Unit Plan which vests in equal installments on January 18, 2023, January 18, 2024, and January 18, 2025, subject to the Reporting Person's continued employment with the Issuer on such vesting date.